Summit X LLC’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-2,273
| Closed | -$24K | – | 448 |
|
|
2020
Q2 | $24K | Buy |
2,273
+523
| +30% | +$5.52K | 0.01% | 203 |
|
|
2020
Q1 | $10K | Buy |
1,750
+167
| +11% | +$954 | ﹤0.01% | 187 |
|
|
2019
Q4 | $10K | Buy |
1,583
+416
| +36% | +$2.63K | ﹤0.01% | 232 |
|
|
2019
Q3 | $8K | Hold |
1,167
| – | – | ﹤0.01% | 228 |
|
|
2019
Q2 | $8K | Hold |
1,167
| – | – | ﹤0.01% | 234 |
|
|
2019
Q1 | $16K | Hold |
1,167
| – | – | 0.01% | 233 |
|
|
2018
Q4 | $14K | Hold |
1,167
| – | – | 0.01% | 201 |
|
|
2018
Q3 | $26K | Buy |
1,167
+84
| +8% | +$1.87K | 0.01% | 220 |
|
|
2018
Q2 | $21K | Buy |
+1,083
| New | +$21K | 0.01% | 206 |
|
|
2018
Q1 | – | Sell |
-367
| Closed | -$8K | – | 184 |
|
|
2017
Q4 | $8K | Hold |
367
| – | – | 0.01% | 175 |
|
|
2017
Q3 | $7K | Hold |
367
| – | – | ﹤0.01% | 180 |
|
|
2017
Q2 | $13K | Buy |
+367
| New | +$13K | 0.01% | 179 |
|